Heng Lin

2.3k total citations · 1 hit paper
26 papers, 944 citations indexed

About

Heng Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heng Lin has authored 26 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heng Lin's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Heng Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Heng Lin collaborates with scholars based in China, United States and Japan. Heng Lin's co-authors include Linda Vatan, Weiping Zou, Ilona Kryczek, Shuang Wei, Wojciech Szeliga, Leslie A. Fecher, Pankaj Vats, Masaki Mandai, Elaine M. Hurt and Paul W. Harms and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Heng Lin

23 papers receiving 937 citations

Hit Papers

Host expression of PD-L1 determines efficacy of PD-L1 pat... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
    2018 449 citations Heng Lin, Shuang Wei et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Lin China 11 566 374 250 189 170 26 944
Alice Guyard France 9 497 0.9× 243 0.6× 336 1.3× 214 1.1× 209 1.2× 25 902
James Strauss United States 14 394 0.7× 370 1.0× 224 0.9× 88 0.5× 76 0.4× 69 837
Aixa Soyano United States 9 713 1.3× 482 1.3× 234 0.9× 229 1.2× 110 0.6× 30 1.1k
Justin D. Saco United States 4 966 1.7× 792 2.1× 368 1.5× 216 1.1× 142 0.8× 5 1.4k
Yi Cheng China 12 400 0.7× 125 0.3× 165 0.7× 318 1.7× 126 0.7× 27 719
Hannah M. Knochelmann United States 14 649 1.1× 542 1.4× 288 1.2× 126 0.7× 113 0.7× 28 1.1k
James M. Leatherman United States 13 461 0.8× 443 1.2× 271 1.1× 84 0.4× 93 0.5× 26 814
Joy Hsu United States 8 581 1.0× 731 2.0× 214 0.9× 100 0.5× 52 0.3× 16 1.0k
Michael Fehlings Singapore 10 370 0.7× 442 1.2× 217 0.9× 59 0.3× 62 0.4× 21 756
Behzad Rowshanravan United Kingdom 7 612 1.1× 647 1.7× 229 0.9× 166 0.9× 85 0.5× 9 1.1k

Countries citing papers authored by Heng Lin

Since Specialization
Citations

This map shows the geographic impact of Heng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Lin more than expected).

Fields of papers citing papers by Heng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Lin. The network helps show where Heng Lin may publish in the future.

Co-authorship network of co-authors of Heng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Lin. A scholar is included among the top collaborators of Heng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Lin. Heng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Heng, Yaping Yuan, Jianming Xu, et al.. (2025). Prediction of adverse pathology in prostate cancer using a multimodal deep learning approach based on [18F]PSMA-1007 PET/CT and multiparametric MRI. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2814–2825. 1 indexed citations
3.
Jing, Tao, et al.. (2025). The potential, challenges, and prospects of polysaccharides from the genus Cistanche as therapeutic agents for aging-related diseases: A review. International Journal of Biological Macromolecules. 312. 144144–144144. 1 indexed citations
4.
5.
Miao, Chao‐Yu, Jian Fang, Heng Lin, et al.. (2025). Exploring the role of multimodal [18F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2087–2095. 1 indexed citations
6.
Xu, Jianming, Lixuan Chen, T.J. Li, et al.. (2025). The predictive value of multiparametric MRI combined with [18F]PSMA-1007 PET/CT for the pathological upgrade in prostate cancer: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4425–4433. 1 indexed citations
7.
Lin, Heng, et al.. (2023). Anti-Angiogenic Agents Combined with Immunotherapy for AdvancedNon-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Combinatorial Chemistry & High Throughput Screening. 27(7). 1081–1091.
8.
Cao, Shuting, Yu‐Wen Hung, Yi-Chang Wang, et al.. (2022). Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 12(13). 6038–6056. 11 indexed citations
9.
Li, Gaopeng, Ilona Kryczek, Jutaek Nam, et al.. (2021). LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nature Cell Biology. 23(5). 526–537. 131 indexed citations
10.
Zhou, Jiajia, Ilona Kryczek, Shasha Li, et al.. (2021). The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. Nature Immunology. 22(4). 460–470. 69 indexed citations
11.
Xie, Xianhe, Xuewen Wang, Su‐Mei Wu, et al.. (2020). Fatal toxic effects related to EGFR tyrosine kinase inhibitors based on 53 cohorts with 9,569 participants. Journal of Thoracic Disease. 12(8). 4057–4069. 9 indexed citations
12.
Huang, Jiaofeng, Heng Lin, Yinlian Wu, et al.. (2020). COVID-19 in posttransplant patients—report of 2 cases. American Journal of Transplantation. 20(7). 1879–1881. 89 indexed citations
13.
Lin, Heng, Shuang Wei, Elaine M. Hurt, et al.. (2018). Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression. Journal of Clinical Investigation. 128(2). 805–815. 449 indexed citations breakdown →
14.
Xie, Xianhe, Huijuan Chen, Haitao Yang, et al.. (2018). Predictive value of positron emission tomography for the prognosis of molecularly targeted therapy in solid tumors. OncoTargets and Therapy. Volume 11. 8885–8899. 3 indexed citations
15.
Lin, Heng, Lina Li, Sijing Zhou, et al.. (2017). Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer. Molecular and Clinical Oncology. 6(3). 296–306. 3 indexed citations
16.
Li, Lina, Heng Lin, Haitao Yang, et al.. (2017). Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer. Journal of Thoracic Disease. 9(8). 2510–2520. 69 indexed citations
17.
18.
Yang, Haitao, Huijuan Chen, Lina Li, et al.. (2017). The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC. Oncotarget. 8(14). 23517–23528. 23 indexed citations
19.
Lin, Heng, Yong Wang, Lihua Wang, et al.. (2014). Effect of Mixed Transplantation of Autologous and Allogeneic Microskin Grafts on Wound Healing in a Rat Model of Acute Skin Defect. PLoS ONE. 9(1). e85672–e85672. 11 indexed citations
20.
Lin, Heng, et al.. (2008). [The ectopic expression and quantitative analysis of Integrin beta1 during wound healing process after mixed microskin transplantation].. PubMed. 24(6). 445–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Guyard Breakdown of academic impact, for papers by James Strauss Breakdown of academic impact, for papers by Aixa Soyano Breakdown of academic impact, for papers by Justin D. Saco Breakdown of academic impact, for papers by Yi Cheng Breakdown of academic impact, for papers by Hannah M. Knochelmann Breakdown of academic impact, for papers by James M. Leatherman Breakdown of academic impact, for papers by Joy Hsu Breakdown of academic impact, for papers by Michael Fehlings Breakdown of academic impact, for papers by Behzad Rowshanravan
Rankless by CCL
2026